Search Results - "Galante, M.I"

Improving the inclusion rate in clinical trials of bladder cancer patients by mapping the quality process of the multidisciplinary team by Vidal, N., Gómez Rivas, J., Galante, M.I., De La Parra, I., Jerez, T., Gonzalez Larriba, J.L., Toledano, C., Fernandez-Montarroso, L., Redondo, E., Moreno-Sierra, J., Puente, J.

Get full text

Robot Assisted Radical Prostatectomy in Kidney Transplant Recipients. Our Clinical Experience and a Systematic Review by Moreno Sierra, Jesús, Ciappara Paniagua, M, Galante Romo, M I, Senovilla Pérez, J L, Redondo González, E, Galindo Herrero, M I, Novo Gómez, N, Blázquez Izquierdo, J

“…Radical prostatectomy is a more skillful procedure in kidney graft recipients. Robotic surgery can provide a useful minimally invasive tool. The study aims to…”
Get more information

902 CIRCULATING TUMOR CELLS (CTC) IN THE THREE TUMOR TYPES OF EPITHELIAL ORIGIN: PROSTATE, BREAST AND COLORECTAL, IN PATIENTS WITH AND WITHOUT METASTASIS by Olivier, Gómez C, Galante, M.I, San, José L.A, Resel, L.E, De, La Orden V, Vidaurreta, M, Veganzones, S, Rafael, S, Arroyo, M, Diaz-Rubio, E, Maestro, M

Get full text

P142 - Osteoprotective Treatment in Metastatic Prostate Cancer and Bone related events by Arevalo, R., Gomez RIvas, J., Galante Romo, M.I., Senovilla Pérez, J.L., Redondo González, E., Gutierrez Hidalgo, B., Mata Deniz, P., Marugan, M.J., Moreno Sierra, J.S.

Get full text

P123 - Efficacy and Safety with Androgen Receptor Targeted Agents in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer by Arevalo, R., Gomez RIvas, J., Galante Romo, M.I., Senovilla Pérez, J.L., De la parra, I., Infante Hernández, S., Mata Deniz, P., Moreno Sierra, J.S.

Get full text

Osteoprotective Treatment in Metastatic Prostate Cancer and Bone related events by Arevalo, R., Gomez RIvas, J., Galante Romo, M.I., Senovilla Pérez, J.L., Redondo González, E., Gutierrez Hidalgo, B., Mata Deniz, P., Marugan, M.J., Moreno Sierra, J.S.

Get full text

Efficacy and Safety with Androgen Receptor Targeted Agents in Older Patients with Metastatic Hormone-Sensitive Prostate Cancer by Arevalo, R., Gomez RIvas, J., Galante Romo, M.I., Senovilla Pérez, J.L., De la parra, I., Infante Hernández, S., Mata Deniz, P., Moreno Sierra, J.S.

Get full text

P235 What are the predictive factors of developing pT0 after radical cystectomy for bladder cancer? by Arevalo, R., Gomez Rivas, J., Galante Romo, M.I., Redondo González, E., Infante Hernández, S., Ibánez Vázquez, L., Marugan, M.J., Mata Deniz, P., Hernandez Teran, A., González-Santander Hernández, C., Moreno Sierra, J.S.

Get full text

Oncologic outcomes in 408 consecutive patient cohort treated with da Vinci robot-assisted radical prostatectomy by Moreno-Sierra, J., Galante-Romo, M.I., Senovilla-Perez, J.L., Redondo-González, E., Galindo-Herrero, I., Barrera-Ortega, J., Vives-Dilmes, R., Ariño-Irujo, J., Fernández-Montarroso, L., Fernández-Perez, C.

“…The objective of this study is to evaluate the general characteristics and oncological results in a cohort of 408 cases submitted to da Vinci Standard 4-armed…”
Get full text